ライフサイエンスコーパス: IFA

1 IFA e-mail messages were sent for 52 883 (93.3%) of the

2 IFA of sPLA2-IIa, -V, and -X in DE CNJ confirmed the upr

3 (-)(2)(0)/CFA, but not with IRBP(1)(-)(2)(0)/IFA.

4 However, exposure of S2-16:IFA-induced cells to inflammatory cytokine IL-12 convert

5 Adoptive transfer of S2-16:IFA-induced splenocytes producing IL-10 suppressed myoca

6 e transfer of IL-10-producing DCs from S2-16:IFA-treated rats also induced protection to EAM in recip

7 Purified DCs from S2-16:IFA-treated rats promoted S2-16-reactive CD4+ T cells to

8 gs, immunizations using CFA but not CpG 1826/IFA as an adjuvant elicited a delayed-type hypersensitiv

9 ive immunizations using CFA but not CpG 1826/IFA as an adjuvant induced disease.

10 unizations using the autoantigen in CpG 1826/IFA result in very low frequencies of Ag-specific IL-17

11 e when cells originated from PLP in CpG 1826/IFA-primed mice.

12 IL-17-secreting cells compared with CpG 1826/IFA.

13 Only 1 of 20 IFA-positive samples tested negative in the rMAP2 ELISA.

14 With a 1:256 IFA titer as the positive cutoff, the agreement, sensiti

15 r the children from 6 to 24 mo (IFA-LNS), 3) IFA (as above) and MNP for the offspring from 6 to 24 mo

16 offspring from 6 to 24 mo (IFA-MNP), and 4) IFA (as above) and no child supplement (IFA-Control).

17 amide (MFA) or 4-hydroperoxyifosfamide (4OOH-IFA), chemically activated forms of CPA and its isomer i

18 d in 9L cells treated with CPA, MFA, or 4OOH-IFA, implicating the mitochondrial apoptotic pathway in

19 Only 3 of 53 IFA-negative samples tested positive on the rMAP2 ELISA.

20 e suggests that the head domain of the MUA-6/IFA-2 is dispensable for its function.

21 Although MUA-6/IFA-2 is expressed embryonically, and plays an essential

22 e filament (cIF) A2 protein and that a MUA-6/IFA-2::GFP fusion protein that rescues the presumptive m

23 ere provided with one daily iron-folic acid (IFA) capsule, one capsule containing multiple micronutri

24 to 24 mo (LNS-LNS), 2) iron and folic acid (IFA) during pregnancy and the first 3 mo postpartum and

25 micronutrients (MMN) or iron and folic acid (IFA) in Indonesia.

26 ore (LAZ) at 24 mo than iron and folic acid (IFA) provided to women during pregnancy and postpartum p

27 pplementation compared with iron-folic acid (IFA) supplementation was examined for its impact on grow

28 e micronutrients (MMN) or iron + folic acid (IFA), versus folic acid (FA) alone, on risk of spontaneo

29 tricted to provision of iron and folic acid (IFA).

30 are comprising CSB+ and iron and folic acid (IFA).

31 s; 48 clusters received iron and folic acid (IFA; 60 mg Fe + 400 mug folic acid) and 16 clusters rece

32 ed with either Freund's incomplete adjuvant (IFA) or phosphate buffered saline (PBS) at monthly inter

33 delivered with incomplete Freund's adjuvant (IFA(OVA)).

34 an emulsion of incomplete Freund's adjuvant (IFA) as a co-delivery vehicle, it was discovered that th

35 to neonates in incomplete Freund's adjuvant (IFA) induced such cells in reduced numbers compared to t

36 immunized with incomplete Freund's adjuvant (IFA) remain susceptible.

37 d with IRBP in incomplete Freund's adjuvant (IFA), lacking mycobacteria (whereas the same mice exhibi

38 E2 peptide2 in incomplete Freund's adjuvant (IFA), resulted in higher antibody production and earlier

39 than benchmark incomplete Freund's adjuvant (IFA).

40 -16 peptide in incomplete Freund's adjuvant (IFA).

41 mulsified with incomplete Freund's adjuvant (IFA).

42 ture- and antigenemia immunofluorescence [AG-IFA]-positive) clinical specimens were positive by the N

43 ens that were positive by cell culture or AG-IFA were positive by the NASBA assay.

44 assay results were obtained earlier than AG-IFA or cell culture results for 55% of the patients and

45 All IFA-negative serum specimens (n = 19) were nonreactive o

46 infected animals, and 94.3% agreement among IFA-negative samples, resulting in a 97.2% overall agree

47 There was 100% agreement among IFA-positive samples from experimentally infected animal

48 ally infected animals, 97.3% agreement among IFA-positive samples from naturally infected animals, an

49 7 to determine how many reports contained an IFA statement, how many IFA messages were sent, and how

50 mmends that the positive titer cutoff for an IFA be 1:256.

51 One donor (0.25%) had an IFA-confirmed reactivity to anti-T. cruzi antibodies.

52 In an IFA study with B. dermatitidis, serum with an anti-mouse

53 In an IFA, MAb 4F11 detected antigens on the S. pneumoniae sur

54 at any laboratories attempting to replace an IFA type 1 to 6 screen with an alternative ELISA careful

55 Immunofluorescence analysis (IFA) and fluorescence in situ hybridization (FISH) show

56 Immunofluorescence analysis (IFA) and plasma membrane isolation and proximity ligatio

57 s were higher in the LNS-LNS (P = 0.016) and IFA-LNS groups (P = 0.006) at 18 mo and in the IFA-MNP g

58 t were higher in the LNS-LNS (P = 0.035) and IFA-MNP (P = 0.002) groups than in the IFA-Control group

59 Our data indicate that IFB-1 and IFA-3 are likely the major cIF isoforms in embryonic epi

60 Two other cIFs, IFA-2 and IFA-3, are expressed in epidermal cells.

61 lls primed in the absence of CpG with Ag and IFA alone appeared to be in a transitional state and had

62 ion of enzyme-linked immunosorbent assay and IFA.Results.

63 assayed by Northern blot, Western blot, and IFA experiments.

64 CD8+ T lymphocytes compared to controls and IFA(OVA) treated mice.

65 11 was 7- to 8-fold more active as a CPA and IFA 4-hydroxylase than 2B1, exhibited a highly desirable

66 Improved catalytic efficiency of CPA and IFA 4-hydroxylation was obtained upon substitution of 2B

67 CPA and IFA metabolism catalyzed by P450s 2B1, 2B4, 2B5, and sev

68 The concordance between EIA and IFA findings was 96.7%.

69 We compared ELISA and IFA testing on sera from 305 suspected cases of Lassa fe

70 n induced with keyhole limpet hemocyanin and IFA did not affect corneal allograft rejection.

71 elative risks of SPB for those using MMN and IFA were 0.99 (95% confidence interval: 0.85, 1.16) and

72 mmunofluorescent antibody (IFA)-positive and IFA-negative dogs.

73 Western blot analysis with an antibody (IFA) that selectively labels all known intermediate fila

74 developed an indirect fluorescence antibody (IFA) test for the detection of antibodies to B. bacillif

75 s detected by indirect fluorescent antibody (IFA) assay.

76 determined by indirect fluorescent antibody (IFA) staining methods.

77 y been by the indirect fluorescent-antibody (IFA) test.

78 Indirect fluorescent-antibody (IFA) testing on cerebrospinal fluid and serum specimens

79 icroscopy (EM), immunofluorescence antibody (IFA) testing of sera, case tracing, containment, and epi

80 By the sandwich immunofluorescent antibody (IFA) method with anti-mouse MBL (MBL-A or -C), we showed

81 es from E. canis immunofluorescent antibody (IFA)-positive and IFA-negative dogs.

82 ually as well as immunofluorescent-antibody (IFA) assay when J774.16 cells were infected with 10-fold

83 Using a two-step diagnostic approach (IFA is performed if the ELISA is positive), we identifie

84 n indirect immunofluorescent-antibody assay (IFA) by using a local human isolate as the source of ant

85 y indirect immunofluorescent-antibody assay (IFA).

86 rnal N. caninum indirect fluorescence assay (IFA) at a 1:200 serum dilution, a relative standard set

87 n blotting, and an immunofluorescence assay (IFA) against a panel of sera from patients with Oroya fe

88 d with an indirect immunofluorescence assay (IFA) and an enzyme-linked immunosorbent assay (ELISA) th

89 tected by indirect immunofluorescence assay (IFA) and immunohistochemistry with a specific rabbit ant

90 confirmed with an immunofluorescence assay (IFA) available through the Centers for Disease Control (

91 to an IgG-specific immunofluorescence assay (IFA) for L. pneumophila serogroups 1 to 6.

92 st to the indirect immunofluorescence assay (IFA) for scrub typhus.

93 ection by indirect immunofluorescence assay (IFA) is the reference standard due to its presumed high

94 Immunofluorescence assay (IFA) of the sPLA2-IIa, -V, and -X isoforms were used to

95 ng either indirect immunofluorescence assay (IFA) or a combination of enzyme-linked immunosorbent ass

96 shown by indirect immunofluorescence assay (IFA) to bind surface antigens of P. carinii derived from

97 al-time PCR and an immunofluorescence assay (IFA) using anti-TTSuV antibodies.

98 ade by an indirect immunofluorescence assay (IFA) using cultured ehrlichia-infected whole cells as an

99 an ELISA and by an immunofluorescence assay (IFA) using PK-15 cells transfected with one of the three

100 nt use of an HHV-8 immunofluorescence assay (IFA) was tested in persons unlikely to be infected with

101 roach involving an immunofluorescence assay (IFA), a differential recombinant IFA, and a plaque-reduc

102 n of culture, MAT, immunofluorescence assay (IFA), lateral flow (LF) and/or PCR targeting the 16S rRN

103 cimens by indirect immunofluorescence assay (IFA).

104 virus by indirect immunofluorescence assay (IFA).

105 ce, as observed by immunofluorescence assay (IFA).

106 dermatitidis in an immunofluorescence assay (IFA).

107 rmined by indirect immunofluorescence assay (IFA).

108 Double-label immunofluorescence assays (IFA) performed with Ad-ZTA-infected HF cells revealed th

109 eutralization and immunofluorescence assays (IFA).

110 ensis by indirect immunofluorescence assays (IFAs).

111 ogical (4 indirect immunofluorescent assays [IFA] and 2 enzyme-linked immunosorbent assays-both HHV8

112 anisms, therefore, contribute to autoantigen:IFA-induced protection from autoimmune disease.

113 rmance was obtained by 2 lytic antigen-based IFAs that showed almost perfect agreement to the referen

114 Because IFA testing for rabies on human specimens may result in

115 ot result in fluorescence, yet serum blocked IFA staining of B. dermatitidis by anti-1,3-beta-glucan

116 Both IFA and CFA, however, provided partial protection from a

117 esumed high sensitivity and specificity, but IFA is impractical, variably reproducible, and cumbersom

118 elating more closely to the confirmatory BVP IFAs, than did the EVP1 EIAs and proved to be more accur

119 In contrast, the EVP1 EIA and BVP1 IFA data for only 3 of 23 and 4 of 32 specimens for IgM

120 The BVP2 EIA and BVP1 IFA results for 20 of 23 and 28 of 32 specimens for IgM

121 Both the BVP2 EIAs and BVP1 IFAs utilize a conformational viral capsid antigen, whil

122 us-based VP1 immunofluorescence assays (BVP1 IFAs) (Biotrin International).

123 By IFA cells expressing neutralization sensitive envelope b

124 By IFA testing, 36 of 38 cattle had antibodies (> or =1:64)

125 By IFA, the patient's serum reacted strongly to two out of

126 tive standard set of 330 cow sera defined by IFA alone, and a set of 4,323 cow sera of unknown N. can

127 n BALF to B. dermatitidis as demonstrated by IFA.

128 ction and was detected on B. dermatitidis by IFA.

129 ositive and had a seroconversion detected by IFA (group A), 10 patients were 16S PCR negative but had

130 egative but had a seroconversion detected by IFA (group B), and 10 patients were 16S PCR negative and

131 lei, especially in nucleoli, was detected by IFA.

132 s that recognize parasitized erythrocytes by IFA and native PyP140/RON4 by immunoblotting but failed

133 convalescent-phase serum samples measured by IFA were 1:83 and 1:575, respectively.

134 s papio IgG antibody titers were measured by IFA.

135 All samples negative by IFA were also found to be negative for antibodies agains

136 hird of the healthy blood donors reactive by IFA were confirmed to be positive by immunoblotting.

137 the influenza A virus subtyping reagents by IFA simultaneously.

138 anti-1,3-beta-glucan antibody, we showed by IFA assay that B. dermatitidis contained 1,3-beta-glucan

139 -C, which bound B. dermatitidis, as shown by IFA assay.

140 ated with canine ehrlichiosis were tested by IFA assay and by recombinant Western immunoblot.

141 ts with culture-confirmed HGE also tested by IFA by using either a human isolate from Wisconsin or an

142 Patients were tested with AdenoPlus, CC-IFA, and PCR to detect the presence of adenovirus.

143 When compared with both CC-IFA and PCR, AdenoPlus showed a sensitivity of 93% (27/2

144 results were found to be positive by both CC-IFA and PCR.

145 sults were found to be positive by either CC-IFA or PCR and 29 patients' results were found to be pos

146 When compared with PCR, CC-IFA showed a sensitivity of 85% (29/34) and specificity

147 When compared only with CC-IFA, AdenoPlus showed a sensitivity of 90% (28/31) and s

148 assay was more sensitive than the whole-cell IFA and ELISA using purified, recombinant histidine-tagg

149 All 16 E. chaffeensis IFA-positive sera reacted with rP30.

150 Two other cIFs, IFA-2 and IFA-3, are expressed in epidermal cells.

151 art is devoid of MHC class II expression, CM-IFA administration delays rejection of fully allogeneic

152 CM/IFA treatment prevents acute rejection of MHC class I-mi

153 t administration of CM together with IFA (CM/IFA) can prevent acute rejection of an allogeneic heart

154 In contrast, IFA-2 is not required for embryonic morphogenesis.

155 respectively, could be used to discriminate IFA dually reacting sera.

156 randomly assigned 262 midwives to distribute IFA (n=15 ,86) or MMN (n=15,804) supplements to 31 290 p

157 ized with MOG 35-55/CFA or MOG 35-55/CpG DNA/IFA.

158 Thirteen dually IFA-reactive sera, three sera that were IFA positive onl

159 incidence in women who started consuming FA, IFA, and MMN before the 12th week of gestation (4.6%, 4.

160 he incidences of SPB for women consuming FA, IFA, and MMN were 5.7%, 5.6% and 5.1%, respectively.

161 were randomly assigned to receive daily FA, IFA, or MMN from the period before 20 weeks' gestation t

162 Starting use of FA, IFA, or MMN supplements before the 12th week of gestatio

163 NS, P = 0.022 for IFA-LNS, and P = 0.009 for IFA-MNP compared with IFA-Control).

164 24 mo (P = 0.008 for LNS-LNS, P = 0.022 for IFA-LNS, and P = 0.009 for IFA-MNP compared with IFA-Con

165 higher in procedural memory than those given IFA, equivalent to the increase in scores with half a ye

166 mortality compared with those of women given IFA (35.5 deaths per 1000 livebirths vs 43 per 1000; rel

167 useful in discriminating dually HME and HGE IFA-reactive sera.

168 Cyclophosphamide (CPA) and ifosfamide (IFA) are oxazaphosphorine anticancer prodrugs metabolize

169 ushi, three different PCR assays, and an IgM IFA.

170 Dx, Inc., Baltimore, Md.), 52%; Biognost IgM IFA test (Bios GmbH Labordiagnostik, Grafelfing, Germany

171 as an alternative reference test to the IgM IFA for the serological diagnosis of scrub typhus.

172 accuracy and is less subjective than the IgM IFA.

173 Use of an immunofluorescence (IFA) test for latent antibody demonstrated that the prev

174 also tested by indirect immunofluorescence (IFA).

175 In IFA-positive subjects, HHV-8 DNA was detected in 3 (16%)

176 EAE conferred by injection of PLPp139-151 in IFA and induced high frequencies of peptide-specific Th1

177 MBP epitope for this strain, administered in IFA.

178 MP4 administration in IFA induced type 2 T cell immunity, IgG1 Abs, and experi

179 MB Igmu(-/-) NOD mice with a beta cell Ag in IFA induced Th2 responses, which spread to other beta ce

180 d that the injection of each of these Ags in IFA was immunogenic and CD4 memory cells producing IL-2,

181 l T reg cell activity to retinal arrestin in IFA).

182 ation with the AIG target Ag, H/K ATPase, in IFA failed to induce disease in normal animals but induc

183 Injection of autoantigens in IFA has been one of the most effective ways of preventin

184 Plasma levels of CA in IFA-treated cancer patients are often difficult to deter

185 DBA/1 mice were immunized with CII in IFA and injected intraperitoneally with rIFN gamma (8,00

186 determined whether immunization with CII in IFA had the capacity to prevent and/or ameliorate collag

187 FA) and treated with a single dose of CII in IFA on the day of immunization or on the day of disease

188 A single intraperitoneal injection of CII in IFA prevented arthritis when given at the time of immuni

189 or rIFN gamma to mice immunized with CII in IFA restored the Th1 response and resulted in the develo

190 The administration of CII in IFA resulted in a profound down-regulation of IFN gamma

191 booster on day 21, which consisted of CII in IFA.

192 njection of bovine type II collagen (CII) in IFA with added Mycobacterium tuberculosis on days 0 and

193 s.c. administration of repeated low doses in IFA.

194 peptide and a pool of epitopes emulsified in IFA elicited similar levels of CD8(+) responses using fr

195 antigen in multiple sclerosis) emulsified in IFA fail to mount lymphoproliferative or cytokine respon

196 ed with peptide or protein Ags emulsified in IFA or related water-in-oil adjuvants develop a highly p

197 ith NY-ESO-1(157-170) peptide (emulsified in IFA) in patients with NY-ESO-1-expressing epithelial ova

198 We show that loss of function in IFA-3 results in defects in morphogenesis indistinguisha

199 observed when MP4 was repeatedly injected in IFA or as soluble Ag s.c.

200 The gland dysfunction observed in IFA-treated mice at earlier time points did not correlat

201 oxp3 expression upon stimulation with OVA in IFA in vivo.

202 A high dose of alpha 146--162 peptide in IFA failed to suppress T cell proliferation and/or clini

203 A high dose of alpha 146--162 peptide in IFA in AChR-immunized mice induced apoptosis of BV6 cell

204 ination of mice with gp100(25-33) peptide in IFA.

205 blished EAE were treated with E2 peptide2 in IFA to develop antibody.

206 inia virus, or epitope delivery as a pool in IFA maintained the overall response pattern; however, ch

207 , but not when the peptide was reinjected in IFA.

208 , Saudi Arabia, 8 reactive sera were seen in IFA but were resolved to be specific for established HCo

209 ptide IRBP(1)(-)(2)(0) in either incomplete (IFA) or complete (CFA) Freund's adjuvant.

210 men received IFA and children received LNSs (IFA-LNS group), 3) women received IFA and children recei

211 Serological assays, specifically lytic IFAs, were the best methodological approach to identify

212 reports contained an IFA statement, how many IFA messages were sent, and how many such messages were

213 nse as revealed by epitope affinity mapping, IFA and inhibition of the complement lysis assays.

214 omen received IFA and children received MNP (IFA-MNP group), and 4) women received IFA and children r

215 m and LNSs for the children from 6 to 24 mo (IFA-LNS), 3) IFA (as above) and MNP for the offspring fr

216 ) and MNP for the offspring from 6 to 24 mo (IFA-MNP), and 4) IFA (as above) and no child supplement

217 The presence of IFA during both acute and convalescent stages of infecti

218 eful prognostic information, the presence of IFA early in the course of illness correlating with deat

219 y and quickly, in contrast to the reading of IFA slides, which was both subjective and labor-intensiv

220 these sera reacted with rP44, regardless of IFA reactivity with the HGE agent.

221 The three HGE-agent-only IFA-positive sera reacted only with rP44, not with rP30.

222 on following immunization with Ags in CFA or IFA or alum.

223 mmunization with GalXM in either complete or IFA was associated with spleen enlargement in BALB/c mic

224 more, we found that i.p. injection with p524/IFA was very effective in providing protection from cycl

225 Peptide/IFA vaccination primed tumor-specific CD8(+) T cells, wh

226 ide in incomplete Freund's adjuvant (peptide/IFA), which is commonly used in clinical cancer vaccine

227 Patients received peptides/IFA with or without interleukin (IL)-12 30 ng/kg to eval

228 However, at this time point IFA-treated mice showed significantly higher frequencies

229 ps at early time points, by late time points IFA-treated mice had higher levels.

230 Because false-positive IFA results could significantly affect patient treatment

231 Regardless of where the positive IFA cutoff titer is placed, however, the sensitivity of

232 results can occur in interpreting the rabies IFA test.

233 ived LNSs (LNS-LNS group), 2) women received IFA and children received LNSs (IFA-LNS group), 3) women

234 ived LNSs (IFA-LNS group), 3) women received IFA and children received MNP (IFA-MNP group), and 4) wo

235 d MNP (IFA-MNP group), and 4) women received IFA and children received no supplements (IFA-Control gr

236 ence assay (IFA), a differential recombinant IFA, and a plaque-reduction serum neutralization assay.

237 cificity was 96.8% for the relative standard IFA-defined sera.

238 In this study, IFA testing was performed on 135 cerebrospinal fluid and

239 quired by the more cumbersome and subjective IFA testing to <20%.

240 This subtyping IFA provides clinical laboratories with a cost-effective

241 th the usual iron and folic acid supplement (IFA) on survival, growth, and morbidity during infancy.

242 d 4) IFA (as above) and no child supplement (IFA-Control).

243 ed IFA and children received no supplements (IFA-Control group).

244 nd indirect immunofluorescent antibody test (IFA) were retrospectively tested with the epank1 primers

245 otoxic T lymphocytes with immune memory than IFA-emulsifying vaccines.

246 ignificantly (P < 0.05) more repeatable than IFA when 2-fold dilutions were used.

247 The IFA is 82% sensitive in detecting B. bacilliformis antib

248 The IFA system is a potentially useful method of communicati

249 The IFA was performed on samples within a range of EIA optic

250 The IFA-induced violation of self tolerance, including the d

251 ly of putative transcription factors and the IFA family of putative transmembrane proteins in C. albi

252 elected radiology reports that contained the IFA statement to identify the imaging modalities and fin

253 total of 56 691 (3.7%) reports contained the IFA statement.

254 95% CI: 0.39, 0.96; P = 0.032) than did the IFA group.

255 -age z score (+0.40; P = 0.022) than did the IFA group; similar differences were found when comparing

256 ely) were significantly greater than for the IFA (79.1 +/- 2.9 cm and -0.87 +/- 0.99) and MMN (79.1 +

257 (58%) to walk alone at age 12 mo than in the IFA (49%) and MMN (49%) groups.

258 S group was 8.9%, compared with 13.7% in the IFA group and 12.9% in the MMN group (P = 0.12).

259 rmediate in the MMN group, and lowest in the IFA group, but except for midupper arm circumference (P

260 to 12 mo of age in the MM group than in the IFA group, but not from 12 to 24 mo of age.

261 at 6 mo of age compared with children in the IFA group.

262 -1.66 +/- 1.03; P = 0.005) than those in the IFA group; in adjusted models, the differences in length

263 ): <-2] was 31.9% in the MM and 35.7% in the IFA groups (P < 0.001); however, LAZ increased during th

264 2.2, and 49.9 +/- 2.1 cm (P = 0.104) in the IFA, MMN, and LNS groups, respectively.

265 ) and IFA-MNP (P = 0.002) groups than in the IFA-Control group at 24 mo.

266 er in the LNS-LNS group at 18 mo than in the IFA-MNP group (OR: 0.70; 95% CI: 0.53, 0.92), but the di

267 A-LNS groups (P = 0.006) at 18 mo and in the IFA-MNP group (P = 0.048) at 24 mo.

268 nventional cutoff titer of 80 is used in the IFA.

269 that triggered the radiologists' use of the IFA system.

270 r cells was shown to be one mechanism of the IFA-induced tolerance.

271 used to examine convalescent-phase sera, the IFA is positive in 93% of bartonellosis cases.

272 CI: 0.12, 1.08; P = 0.040) earlier than the IFA group and standing with assistance earlier than the

273 In addition, while the IFA-primed T cells acted as suppressor cells, in that th

274 rcumference (+0.15 z score compared with the IFA-Control group); these outcomes did not differ betwee

275 364), and 24 (n = 3379) mo.Compared with the IFA-Control group, motor development scores were higher

276 ficantly higher LAZ (+0.13 compared with the IFA-MNP group) and head circumference (+0.15 z score com

277 of the recombinant proteins compared to the IFAs was 96% for rP28, 88% for P43 and 63% for P140.

278 There was 100% agreement using IFA-negative samples and 95% agreement using IFA-positiv

279 IFA-negative samples and 95% agreement using IFA-positive samples, resulting in a 97.5% overall agree

280 of low SLP doses in the slow-release vehicle IFA prevented the anaphylaxis after repeated vaccination

281 showed a positive coefficient of MMN versus IFA (p=0.0431) with effect sizes from 0.00-0.18 SD.

282 Among the 22 samples that were IFA positive for E. canis, 100% reacted with rP43, 96% r

283 ally IFA-reactive sera, three sera that were IFA positive only with E. chaffeensis, and three sera th

284 ith E. chaffeensis, and three sera that were IFA positive only with the HGE agent were examined by We

285 While IFA-treated mice had significantly decreased salivary se

286 With IFA, approximately 50% of metabolism proceeded via N-dec

287 assay, demonstrating rates of agreement with IFA of >/=98%.

288 uivalent or superior rates of agreement with IFA-positive specimens across all titers examined.

289 e samples, and there was 100% agreement with IFA.

290 (ELISA) for use alone or in combination with IFA.

291 ternal MMN supplementation, as compared with IFA, can reduce early infant mortality, especially in un

292 rnal supplementation with MMN, compared with IFA, on fetal loss and infant death in the setting of ro

293 LNS, and P = 0.009 for IFA-MNP compared with IFA-Control).

294 r the RUSF, CSB+ with UNIMMAP, and CSB+ with IFA groups, respectively; P = 0.03).

295 groups (17%, 18%, and 24% for the CSB+ with IFA, RUSF, and CSB+ with UNIMMAP groups, respectively; P

296 Mtb 8.4 recombinant protein formulated with IFA elicited strong CD4(+) T cell and CD8(+) CTL respons

297 show that administration of CM together with IFA (CM/IFA) can prevent acute rejection of an allogenei

298 from seven melanoma patients vaccinated with IFA, CpG, and the native/EAA or analog/ELA Melan-A(MART-

299 This analysis included 1057 women (IFA = 349, MMN = 354, LNS = 354).

300 Among primiparous women (IFA = 131; MMN = 110; LNS = 128), the LNS group had grea